Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
76,000
+400 (0.53%)
At close: Mar 19, 2026
Market Cap650.57B +49.2%
Revenue (ttm)14.90B +70.6%
Net Income-117.78M
EPS-606.21
Shares Out8.20M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume95,062
Average Volume83,615
Open74,300
Previous Close75,600
Day's Range73,200 - 77,700
52-Week Range35,600 - 101,000
Betan/a
RSI57.36
Earnings DateMar 20, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements